From there, we tailor a regenerative plan that may include NAD+ for cellular support, bioidentical hormones for balance, and PRF for tissue and joint repair
Other Options May Be Preferable For People Who: Specifically need FDA-approved finished drug products
NAD+ precursors including NMN and NR are generally well-tolerated and are not known to interact with GLP-1 receptor agonists
The broader health impacts of GLP-1s are just beginning to be felt, showing incredible promise in improving metabolic health and even treating addiction
Your provider adjusts compound selection, dose strategy, and combination ratios based on whether you carry variants associated with GLP-1 resistance, GIP-responsive profiles, or metabolic inefficiency
Some people may experience a slower progression, while others may have a rapid rupture within hours of symptom onset